{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T16:05:23Z","timestamp":1761581123983},"reference-count":47,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emergency Medicine Clinics of North America"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.emc.2013.07.003","type":"journal-article","created":{"date-parts":[[2013,9,13]],"date-time":"2013-09-13T02:30:12Z","timestamp":1379039412000},"page":"1035-1044","source":"Crossref","is-referenced-by-count":11,"title":["Hyperthermia Caused by Drug Interactions and Adverse Reactions"],"prefix":"10.1016","volume":"31","author":[{"given":"Mary S.","family":"Paden","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucy","family":"Franjic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Eliza","family":"Halcomb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.emc.2013.07.003_bib1","series-title":"The numbers count: mental disorders in America","year":"2013"},{"key":"10.1016\/j.emc.2013.07.003_bib2","doi-asserted-by":"crossref","first-page":"7673","DOI":"10.1073\/pnas.97.14.7673","article-title":"Schizophrenia: more dopamine, more D2 receptors","volume":"97","author":"Seeman","year":"2000","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.emc.2013.07.003_bib3","series-title":"Neuroleptic malignant syndrome and related conditions","author":"Mann","year":"2003"},{"key":"10.1016\/j.emc.2013.07.003_bib4","first-page":"145","article-title":"Un neuroleptique majeur non phenothiazinique et non r\u00e9serpinique, l\u2019halop\u00e9ridol, dans le traitement des psychoses","volume":"18","author":"Delay","year":"1960","journal-title":"Ann Med Psychol"},{"key":"10.1016\/j.emc.2013.07.003_bib5","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1023\/A:1010389215197","article-title":"Clinical management of neuroleptic malignant syndrome","volume":"72","author":"Susman","year":"2001","journal-title":"Psychiatr Q"},{"key":"10.1016\/j.emc.2013.07.003_bib6","doi-asserted-by":"crossref","first-page":"464","DOI":"10.4088\/JCP.v65n0403","article-title":"Neuroleptic malignant syndrome and atypical antipsychotic drugs","volume":"65","author":"Ananth","year":"2004","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"3","key":"10.1016\/j.emc.2013.07.003_bib7","first-page":"58","article-title":"Neuroleptic malignant syndrome: a brief review","volume":"15","author":"Bottoni","year":"2002","journal-title":"Hospital Physician"},{"key":"10.1016\/j.emc.2013.07.003_bib8","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/0006-3223(87)90010-2","article-title":"Neuroleptic malignant syndrome: review and analysis of 115 cases","volume":"22","author":"Addonizio","year":"1987","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.emc.2013.07.003_bib9","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0025-7125(16)30278-4","article-title":"Neuroleptic malignant syndrome","volume":"77","author":"Caroff","year":"1993","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.emc.2013.07.003_bib10","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1176\/appi.ajp.164.6.870","article-title":"Neuroleptic malignant syndrome","volume":"164","author":"Strawn","year":"2007","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.emc.2013.07.003_bib11","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1176\/ajp.142.10.1137","article-title":"Neuroleptic malignant syndrome","volume":"142","author":"Levenson","year":"1985","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.emc.2013.07.003_bib12","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1212\/WNL.31.2.132","article-title":"Neuroleptic malignant syndrome: a pathogenetic role for dopamine receptor blockade?","volume":"31","author":"Henderson","year":"1981","journal-title":"Neurology"},{"key":"10.1016\/j.emc.2013.07.003_bib13","first-page":"477","article-title":"Neuroleptic malignant syndrome and malignant hyperthermia","volume":"21","author":"Caroff","year":"1993","journal-title":"Anaesth Intensive Care"},{"key":"10.1016\/j.emc.2013.07.003_bib14","first-page":"79","article-title":"The neuroleptic malignant syndrome","volume":"41","author":"Caroff","year":"1980","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.emc.2013.07.003_bib15","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1113\/jphysiol.1978.sp012476","article-title":"Dopamine receptors in the central thermoregulatory pathways of the rat","volume":"282","author":"Cox","year":"1978","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.emc.2013.07.003_bib16","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1212\/WNL.31.8.1022","article-title":"Neuroleptic malignant syndrome caused by dopamine depleting drugs in a patient with Huntington\u2019s chorea","volume":"31","author":"Burke","year":"1981","journal-title":"Neurology"},{"key":"10.1016\/j.emc.2013.07.003_bib17","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/00005053-198105000-00011","article-title":"Neuroleptic malignant syndrome-like state following a withdrawal of antiparkinsonian drug","volume":"169","author":"Toru","year":"1981","journal-title":"J\u00a0Nerv Ment Dis"},{"key":"10.1016\/j.emc.2013.07.003_bib18","first-page":"302","article-title":"Detection and management of the neuroleptic malignant syndrome","volume":"3","author":"Bond","year":"1984","journal-title":"Clin Pharm"},{"key":"10.1016\/j.emc.2013.07.003_bib19","first-page":"381","article-title":"A\u00a0case of neuroleptic malignant syndrome successfully treated with amantadine","volume":"43","author":"McCarron","year":"1982","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.emc.2013.07.003_bib20","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/0006-3223(92)90037-Z","article-title":"Thermoregulatory dysfunction in neuroleptic malignant syndrome","volume":"32","author":"Gurrera","year":"1992","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.emc.2013.07.003_bib21","series-title":"Neuroleptic malignant syndrome: a clinical approach","author":"Addonizio","year":"1991"},{"key":"10.1016\/j.emc.2013.07.003_bib22","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/bja\/85.1.129","article-title":"Neuroleptic malignant syndrome","volume":"85","author":"Adnet","year":"2000","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.emc.2013.07.003_bib23","first-page":"389","article-title":"Update for nurse anesthetists: neuroleptic malignant syndrome","volume":"71","author":"Waldorf","year":"2003","journal-title":"AANA J"},{"key":"10.1016\/j.emc.2013.07.003_bib24","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ncl.2003.12.006","article-title":"The evaluation and management of patients with neuroleptic malignant syndrome","volume":"22","author":"Banushali","year":"2004","journal-title":"Neurol Clin"},{"key":"10.1016\/j.emc.2013.07.003_bib25","series-title":"American Psychiatric Association: Diagnostic and statistical manual of mental disorders (DSM-IV)","first-page":"739","year":"1994"},{"key":"10.1016\/j.emc.2013.07.003_bib26","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(80)92764-6","article-title":"A\u00a0physiological body-cooling unit for treatment of heat stroke","volume":"1","author":"Weiner","year":"1980","journal-title":"Lancet"},{"key":"10.1016\/j.emc.2013.07.003_bib27","first-page":"526","article-title":"Amantadine in the neuroleptic malignant syndrome","volume":"45","author":"Gangadhar","year":"1984","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.emc.2013.07.003_bib28","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0006-3223(96)00519-7","article-title":"Intravenous injection of levodopa is more effective than dantrolene as a therapy for neuroleptic malignant syndrome","volume":"41","author":"Nisijima","year":"1997","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.emc.2013.07.003_bib29","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1001\/archinte.1989.00390090009002","article-title":"Neuroleptic malignant syndrome: review of response to therapy","volume":"149","author":"Rosenberg","year":"1989","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.emc.2013.07.003_bib30","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1177\/106002809703100120","article-title":"Carbidopa\/levodopa in treatment of neuroleptic malignant syndrome","volume":"31","author":"Shoop","year":"1997","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.emc.2013.07.003_bib31","doi-asserted-by":"crossref","first-page":"R4","DOI":"10.1186\/cc5148","article-title":"Managing an effective treatment for neuroleptic malignant syndrome","volume":"11","author":"Reulbach","year":"2007","journal-title":"Crit Care"},{"key":"10.1016\/j.emc.2013.07.003_bib32","series-title":"Tintinalli's emergency medicine: a comprehensive study guide","first-page":"1202","author":"Tintinalli","year":"2011"},{"issue":"5","key":"10.1016\/j.emc.2013.07.003_bib33","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4088\/PCC.08l00690","article-title":"Serotonin syndrome associated with tramadol","volume":"11","author":"Takeshita","year":"2009","journal-title":"Prim Care Companion J Clin Psychiatry"},{"issue":"6","key":"10.1016\/j.emc.2013.07.003_bib34","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/bja\/ael078","article-title":"Acute toxic effects of \u2018Ecstasy\u2019 (MDMA) and related compounds: overview of pathophysiology and clinical management","volume":"96","author":"Hall","year":"2006","journal-title":"Br J Anaesth"},{"issue":"8","key":"10.1016\/j.emc.2013.07.003_bib35","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1503\/cmaj.061217","article-title":"Health and drug alerts: triptan migraine treatments and antidepressants: risk of serotonin syndrome","volume":"175","author":"Wooltorton","year":"2006","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.emc.2013.07.003_bib36","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0749-0704(05)70368-7","article-title":"Serotonin syndrome: a clinical update","volume":"13","author":"Mills","year":"1997","journal-title":"Crit Care Clin"},{"key":"10.1016\/j.emc.2013.07.003_bib37","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.ajem.2005.02.018","article-title":"Identifying serotonin syndrome in the emergency department","volume":"23","author":"Christensen","year":"2005","journal-title":"Am J Emerg Med"},{"issue":"7","key":"10.1016\/j.emc.2013.07.003_bib38","first-page":"988","article-title":"Recognition and treatment of serotonin syndrome","volume":"54","author":"Frank","year":"2008","journal-title":"Can Fam Physician"},{"issue":"6","key":"10.1016\/j.emc.2013.07.003_bib39","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/bja\/34.6.395","article-title":"Anaesthetic deaths in a family","volume":"34","author":"Denborough","year":"1962","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.emc.2013.07.003_bib40","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1750-1172-2-21","article-title":"Malignant hyperthermia","volume":"2","author":"Rosenberg","year":"2007","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"10.1016\/j.emc.2013.07.003_bib41","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/mus.20068","article-title":"Mutation analysis of two patients with hypokalemic periodic paralysis and suspected malignant hyperthermia","volume":"30","author":"Marchant","year":"2004","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.emc.2013.07.003_bib42","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/hmg\/3.6.969","article-title":"Localization of the gene encoding the alpha 2\/delta-subunits of the L-type voltage-dependent calcium channel to chromosome 7q and analysis of the segregation of flanking markers in malignant hyperthermia susceptible families","volume":"3","author":"Iles","year":"1994","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.emc.2013.07.003_bib43","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1113\/jphysiol.2009.171967","article-title":"Calsequestrin-1: a new candidate gene for malignant hyperthermia and exertional\/environmental heat stroke","volume":"587","author":"Protasi","year":"2009","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.emc.2013.07.003_bib44","first-page":"287","article-title":"Ryanodine receptor structure, function and pathophysiology","volume":"vol. 41","author":"Zissimopoulos","year":"2007"},{"issue":"3","key":"10.1016\/j.emc.2013.07.003_bib45","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1093\/bja\/60.3.274","article-title":"Malignant hyperthermia: biochemical aspects of the acute episode","volume":"60","author":"Heffron","year":"1988","journal-title":"Br J Anaesth"},{"issue":"1","key":"10.1016\/j.emc.2013.07.003_bib46","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/bja\/47.1.62","article-title":"Control of the malignant hyperpyrexic syndrome in MHS swine by dantrolene sodium","volume":"47","author":"Harrison","year":"1975","journal-title":"Br J Anaesth"},{"issue":"5","key":"10.1016\/j.emc.2013.07.003_bib47","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1213\/00000539-198405000-00001","article-title":"Hyperkalemia and cardiovascular collapse after verapamil and dantrolene administration in swine","volume":"63","author":"Saltzman","year":"1984","journal-title":"Anesth Analg"}],"container-title":["Emergency Medicine Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733862713000692?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733862713000692?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T22:17:18Z","timestamp":1563920238000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733862713000692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0733862713000692"],"URL":"https:\/\/doi.org\/10.1016\/j.emc.2013.07.003","relation":{},"ISSN":["0733-8627"],"issn-type":[{"value":"0733-8627","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}